Allen R. Nissenson, MD, FACP
          
          (2-AUDIO CD DISC SET)  Industry Speaks III: IV Iron Therapy: A Practical Approach to Patient Management
UMA53-041/042
          
25th Annual Conference on Peritoneal Dialysis ~ 2005
          
         
        
          Treating the Iron Dextran Intolerant Patient - Chaim Charytan, MD
 
Determining the Optimal Maintenance Dose - Allen R. Nissenson, MD
 
Safety of IV Iron Agents - George R. Bailie, PharmD, PhD
Case Studies in IV Iron Agents - Joel D. Glickman, MD
 
Discussion
 
Adjourn